MIMETAS Unveils Scalable, Self-Assembling Human Blood-Brain Barrier Model
Scientists at MIMETAS have published a groundbreaking study detailing a scalable, self-assembling human blood-brain barrier (BBB) model. This innovative model successfully combines crucial physiological relevance with high-throughput capabilities, addressing long-standing challenges in central nervous system research.
A Breakthrough in BBB Research
The blood-brain barrier is vital for maintaining central nervous system health but presents significant hurdles for drug development and the study of neurological diseases. The new MIMETAS model offers a robust solution, facilitating deeper understanding and more effective therapeutic strategies.
Introducing the MIMETAS BBB Model
The study introduces a 3D brain microvasculature model that operates under unidirectional flow. Developed using the OrganoPlate® Graft 48 UF platform and supported by MIMETAS' Uniflow technology, this model replicates the complex architecture of the BBB.
It consists of primary brain microvascular endothelial cells, pericytes, and astrocytes. These components are designed to self-organize into perfusable vascular networks, which remain viable for at least 14 days.
Unlike some existing BBB-on-a-chip systems, this model supports gravity-driven, unidirectional perfusion without requiring pumps or syringes, which more closely mimics physiological cerebral blood flow.
Physiological Relevance Meets High-Throughput
A key advantage of this system is its unique perfusion mechanism. The gravity-driven, unidirectional flow eliminates the need for pumps or syringes, offering a more physiologically accurate representation of cerebral blood flow.
Moreover, the system allows for 48 BBB networks to be cultured in parallel on a single plate, making it exceptionally suitable for higher-throughput studies and large-scale screenings.
Key Findings and Enhanced Barrier Function
Comprehensive characterization of the model revealed significant findings. Co-culture with pericytes and astrocytes substantially enhanced barrier function and vascular organization.
Triculture networks displayed:
- Smaller vessel diameters
- Increased branching
- Tighter barrier integrity
- Stronger alignment with the flow direction when compared to endothelial monocultures.
Functional assays further confirmed robust perfusion, retention of high-molecular-weight tracers, and consistent unidirectional flow through the microvasculature.
Transformative Potential for Drug Development and Disease Study
The combination of physiological relevance, scalability, and ease of use positions this model as an invaluable tool for studying BBB biology in health and disease.
Potential applications are broad and impactful, including:
- Drug permeability and delivery studies.
- Investigation of BBB dysfunction in neurological disorders such as stroke or neuroinflammation.
- Assessment of BBB-restorative therapies.